David Hollander - Sep 29, 2023 Form 4 Insider Report for KIORA PHARMACEUTICALS INC (KPRX)

Role
Director
Signature
/s/ Melissa Tosca, Attorney-in-Fact
Stock symbol
KPRX
Transactions as of
Sep 29, 2023
Transactions value $
$0
Form type
4
Date filed
10/3/2023, 04:44 PM
Previous filing
Mar 7, 2023
Next filing
Feb 29, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KPRX Stock Option (right to buy) Award $0 0 0% $0.00* 5K Sep 29, 2023 Common Stock 5K $0.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become fully exercisable on September 29, 2024.